These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Comparison of Triple-Drug Transcatheter Arterial Chemoembolization (TACE) With Single-Drug TACE Using Doxorubicin-Eluting Beads: Long-Term Survival in 313 Patients. Gomes AS, Monteleone PA, Sayre JW, Finn RS, Sadeghi S, Tong MJ, Britten CD, Busuttil RW. AJR Am J Roentgenol; 2017 Oct; 209(4):722-732. PubMed ID: 28705059 [Abstract] [Full Text] [Related]
8. Application of DC beads in hepatocellular carcinoma: clinical and radiological results of a drug delivery device for transcatheter superselective arterial embolization. Sadick M, Haas S, Loehr M, Elshwi M, Singer MV, Brade J, Schoenberg SO, Diehl SJ. Onkologie; 2010 Oct; 33(1-2):31-7. PubMed ID: 20164659 [Abstract] [Full Text] [Related]
10. Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma. Song MJ, Chun HJ, Song DS, Kim HY, Yoo SH, Park CH, Bae SH, Choi JY, Chang UI, Yang JM, Lee HG, Yoon SK. J Hepatol; 2012 Dec; 57(6):1244-50. PubMed ID: 22824821 [Abstract] [Full Text] [Related]
20. Doxorubicin eluting beads - 1: effects of drug loading on bead characteristics and drug distribution. Lewis AL, Gonzalez MV, Leppard SW, Brown JE, Stratford PW, Phillips GJ, Lloyd AW. J Mater Sci Mater Med; 2007 Sep; 18(9):1691-9. PubMed ID: 17483878 [Abstract] [Full Text] [Related] Page: [Next] [New Search]